Clinical Trial Update: Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC [Phase 3]

View source ↗

Summary

This document provides a clinical trial update on a Phase 3 study comparing FOLF(HA)Iri to FOLFIRI in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLF(HA)Iri
• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)

Snippet

Sponsor: Alchemia Oncology | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: UNKNOWN